Pharmacogenetic Genotyping
Pharmacogenetic genotyping identifies inherited variations in the genes that control how individuals absorb, metabolize, and respond to medications. These tests explain why a standard dose can be ineffective for one patient and cause an adverse reaction in another, giving clinicians the genetic evidence to choose the right drug at the right dose from the outset.
Atila's SNP genotyping approach covers clinically established variants across 35 pharmacogenes, configurable as a comprehensive panel or as focused sub panels built around a customer's therapeutic area and testing volume. Every panel is supported by Atila's data analysis software, which converts raw instrument signal into genotypes, star alleles, and predicted metabolizer phenotypes, and by an optional reporting service that translates those results into drug-specific guidance aligned with current CPIC recommendations.
